scholarly article | Q13442814 |
P2093 | author name string | Bin Zhou | |
Xiaohui Zhao | |||
Quan Jiang | |||
Ruihua Chen | |||
Xiaozhen Jiang | |||
P2860 | cites work | Diabetes duration and cause-specific mortality in the Verona Diabetes Study | Q74150687 |
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes | Q82938218 | ||
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer | Q24642646 | ||
CD36: implications in cardiovascular disease | Q24678338 | ||
Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1β, BDNF and synaptic plasticity | Q26853611 | ||
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | Q29618673 | ||
Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population | Q33600269 | ||
Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36 | Q33606906 | ||
Increased CD36 expression signals monocyte activation among patients with type 2 diabetes. | Q34084613 | ||
Relationship between single nucleotide polymorphisms in the 3'-untranslated region of the vascular endothelial growth factor gene and susceptibility to diabetic peripheral neuropathy in China | Q34466706 | ||
CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis. | Q34471077 | ||
Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis | Q34496967 | ||
Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis | Q34604937 | ||
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? | Q34608998 | ||
Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment | Q35563671 | ||
Genetic variant of BDNF (Val66Met) polymorphism attenuates stroke-induced angiogenic responses by enhancing anti-angiogenic mediator CD36 expression | Q35840890 | ||
Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients with and without microangiopathy | Q36105705 | ||
Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies | Q36311526 | ||
CD36 mediates the innate host response to beta-amyloid | Q36370903 | ||
Innate immunity receptor CD36 promotes cerebral amyloid angiopathy | Q36637524 | ||
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications | Q36906245 | ||
Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans | Q37106597 | ||
Subclinical atherosclerotic calcification and cognitive functioning in middle-aged adults: the CARDIA study | Q37309799 | ||
Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function | Q38422040 | ||
The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation | Q39876607 | ||
Carotid artery atherosclerosis is correlated with cognitive impairment in an elderly urban Chinese non-stroke population | Q40133239 | ||
Complications of Diabetes | Q42390608 | ||
Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk | Q43170056 | ||
Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: a cross-section study | Q44244627 | ||
Low BDNF is associated with cognitive deficits in patients with type 2 diabetes | Q44345365 | ||
Serum levels of 25-hydroxyvitamin D are associated with cognitive impairment in type 2 diabetic adults | Q46254739 | ||
Relation of diabetes to mild cognitive impairment | Q48210463 | ||
PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice. | Q48273067 | ||
The leukocyte expression of CD36 is low in patients with Alzheimer's disease and mild cognitive impairment | Q48606051 | ||
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. | Q51535629 | ||
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. | Q53385146 | ||
Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability | Q61066384 | ||
15-year longitudinal study of blood pressure and dementia | Q71021081 | ||
P433 | issue | 5 | |
P304 | page(s) | 1031-1039 | |
P577 | publication date | 2016-06-22 | |
P1433 | published in | Archives of Medical Science | Q15753010 |
P1476 | title | Plasma soluble CD36, carotid intima-media thickness and cognitive function in patients with type 2 diabetes | |
P478 | volume | 13 |
Search more.